José
Alcamí Pertejo
Publicacións nas que colabora con José Alcamí Pertejo (12)
2013
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
2012
2010
-
Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants
Antiviral Research, Vol. 88, Núm. 2, pp. 152-159
2008
-
Optimal use of maraviroc in clinical practice
AIDS, Vol. 22, Núm. 17, pp. 2231-2240
2007
-
Genetic analysis of the long terminal repeat (LTR) promoter region in HIV-1-infected individuals with different rates of disease progression
Virus Genes, Vol. 34, Núm. 2, pp. 111-116
2006
-
New findings on transcription regulation across different HIV-1 subtypes
AIDS Reviews, Vol. 8, Núm. 1, pp. 9-16
2002
-
Evaluation of the Abbott LCx quantitative assay for measurement of human immunodeficiency virus RNA in plasma
Journal of Clinical Microbiology, Vol. 40, Núm. 4, pp. 1518-1521
-
Herramientas de laboratorio para individualizar el tratamiento: Resistencias y niveles de fármacos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 20, Núm. SUPPL.2, pp. 35-47
-
Multicenter study of the LCx® HIV RNA Quantitative Assay - A new competitive reverse transcriptase-PCR which targets pol genomic region of HIV-1 for the measurement of type B, non-type B and group O HIV-1 RNA
Clinical Chemistry and Laboratory Medicine, Vol. 40, Núm. 7, pp. 698-704
2001
-
GESIDA Consensus document on the use of resistance studies in clinical practice
Enfermedades infecciosas y microbiología clínica
1999
-
CCR5 genotype and HIV-1 infection in perinatally-exposed infants
Journal of Infection, Vol. 38, Núm. 1, pp. 9-11
1998
-
LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression
Virus Research, Vol. 57, Núm. 1, pp. 11-20